CONSTRUCTION OF GENTILLY-2 NUCLEAR POWER STATION = CONSTRUCTION DE LA CENTRALE NUCLEAIRE GENTILLY-2BOURGET Y.sdIN: NUCL. ENERGY SYMP.; MONTREAL; 1974; S.L.; AT. ENERGY CANADA; DA. S.D.; PP. 1-9Conference Paper

C-Jun modulates apoptosis but not terminal cell differentiation in murine erythroleukemia cellsPOINDESSOUS-JAZAT, V; AUGERY-BOURGET, Y; ROBERT-LEZENES, J et al.Leukemia. 2002, Vol 16, Num 2, pp 233-243, issn 0887-6924Article

Interleukin 2 receptorsALLOUCHE, M; SAHRAOUI, Y; AUGERY-BOURGET, Y et al.Leukemia research. 1990, Vol 14, Num 8, pp 699-703, issn 0145-2126, 5 p.Article

NF-E2p18/mafK is required in DMSO-induced differentiation of Friend erythroleukemia cells by enhancing NF-E2 activityFRANCASTEL, C; POINDESSOUS-JAZAT, V; AUGERY-BOURGET, Y et al.Leukemia. 1997, Vol 11, Num 2, pp 273-280, issn 0887-6924Article

Phorbol myristate acetate induces both high affinity and low-affinity interleukin 2-receptors on a pre-B leukemic cell lineALLOUCHE, M; GEORGOULIAS, V; AUGERY-BOURGET, Y et al.Leukemia research. 1990, Vol 14, Num 4, pp 353-361, issn 0145-2126, 8 p.Article

Expression of the interleukin-2 receptor on human fibroblasts and its biological significancePLAISANCE, S; RUBINSTEIN, E; ALILECHE, A et al.International immunology. 1992, Vol 4, Num 7, pp 739-746, issn 0953-8178Article

c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cellsFRANCASTEL, C; AUGERY-BOURGET, Y; PRENANT, M et al.Oncogene (Basingstoke). 1997, Vol 14, Num 7, pp 873-877, issn 0950-9232Article

Impaired in-vitro proliferation of hemopoietic precursors in HIV-1-infected subjectsLUNARDI-ISKANDAR, Y; GEORGOULIAS, V; BERTOLI, A. M et al.Leukemia research. 1989, Vol 13, Num 7, pp 573-581, issn 0145-2126Article

Autocrine growth and progression of murine X-ray-induced T cell lymphomasHAAS, M; MALLY, M. I; BOGENBERGER, J. M et al.EMBO journal (Print). 1986, Vol 5, Num 8, pp 1775-1782, issn 0261-4189Article